Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Oct 18, 2022--
The "In Vitro Diagnostics Market, by Product Type, by Technology, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
In vitro diagnostic can be described as the reagents, instruments and systems intended for the diagnosis of disease or other conditions, including the determination of health status, in order to cure, alleviate, treat or prevent disease or its consequences. These products are intended for collection, processing and analysis of samples taken from the human body. They are used for taking and examining biological samples such as blood, saliva or tissue. Samples can be taken from the nose or throat, or from a vein or fingertip.
In recent years, the value of IVDs has gained increasing recognition due to their potential to save lives through earlier diagnosis of disease. The use of IVDs to predict underlying genetic diseases in addition to diagnostic screening can also prevent unnecessary patient suffering and reduce the amount of treatment required.
Market Dynamics
Increasing adoption of inorganic growth strategies by key players in market such as collaboration is expected to drive market growth over the forecast period.
For instance, in July 2022, ELITechGroup, manufacturer and distributors of in vitro diagnostic equipment and reagents for clinical chemistry, microbiology, molecular diagnostics, hematology, cytology, and sweat test systems and InfanDx AG, developing diagnostic solutions for acute and critical care conditions in newborns, announced at the ongoing 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois, U.S., the signing of a Memorandum of Understanding (MoU) to collaborate on the development and manufacturing of InfanDx' HypoxE Test for ELITechGroup's family of Selectra Pro clinical chemistry analyzers.
The parties intend to enter into a formal collaboration agreement once the biomarkers targeted by InfanDx' HypoxE Test are validated in patients from the recently closed Biomarkers And Neurological Outcome in Neonates (BANON) cohort study.
Key features of the study:
Detailed Segmentation: Global In-Vitro Diagnostics Market, By Product Type:
Global In-Vitro Diagnostics Market, By Technology:
Global In-Vitro Diagnostics Market, By Application:
Global In-Vitro Diagnostics Market, By End User:
Global In-Vitro Diagnostics Market, By Region
Company Profiles
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global In-Vitro Diagnostics Market, By Product Type, 2017 - 2030, (US$ Million)
6. Global In-Vitro Diagnostics Market, By Technology, 2017 - 2030, (US$ Million)
7. Global In-Vitro Diagnostics Market, By Application, 2017 - 2030, (US$ Million)
8. Global In-Vitro Diagnostics Market, By Region, 2017 - 2030, (US$ Million)
9. Competitive Landscape
10. Section
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/7nc9fq
View source version on businesswire.com:https://www.businesswire.com/news/home/20221018005723/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/18/2022 05:38 AM/DISC: 10/18/2022 05:38 AM
http://www.businesswire.com/news/home/20221018005723/en